Risk and Safety of Probiotics
Open accessThe DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Abstract
Probiotics have been used safely for years. Safety outcomes are inconsistently reported in published clinical trials. In 2011, a report released by the Agency for Healthcare Research and Quality concluded that, although the existing probiotic clinical trials reveal no evidence of increased risk, "the current literature is not well equipped to answer questions on the safety of probiotics in intervention studies with confidence." Critics point out that the preponderance of evidence, including the long history of safe probiotic use as well as data from clinical trials, and animal and in vitro studies all support the assumption that probiotics are generally safe for most populations. Theoretical risks have been described in case reports, clinical trial results and experimental models, include systemic infections, deleterious metabolic activities, excessive immune stimulation in susceptible individuals, gene transfer and gastrointestinal side effects. More research is needed to properly describe the incidence and severity of adverse events related to probiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although probiotics are widely used and generally considered safe for healthy individuals, accumulating evidence indicates that their safety profile varies significantly depending on the strain, dose, host, and context, with rare but clinically significant adverse events reported in vulnerable populations.”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Vulnerable populations (newborns, immunocompromised individuals, and critically ill individuals) are at greater risk; therefore, assessing regulatory compliance requires a combination of biochemical and metabolomic studies, whole genome sequencing for virulence, antibiotic resistance genes and motility mapping [63,66,87].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, in the same year, Doron et al. (2015) conducted an analysis based solely on traditional literature review methods based on the results of 622 probiotic safety studies [63].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with established guidance, probiotic safety is linked to intended use, strain identity, and historical evidence of safe exposure, and is distinct from classical pathogenic risk assessment.20-22”
From Safety and efficacy concerns in Indian probiotics: Insights from whole-genome sequencing and in vitro assessment (2026) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The presence of such ARGs and VFs may have clinical relevance, particularly in immunocompromised individuals or those with disrupted gut barriers, where opportunities for opportunistic infection or horizontal gene transfer may be increased.22,29-35”
From Safety and efficacy concerns in Indian probiotics: Insights from whole-genome sequencing and in vitro assessment (2026) · cites this paper as [22]
Experimental — accuracy not yet measured
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial
Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., & Isolauri, E. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04259-8 · Cited by 2,432 · cited 1×
“Pregnant women [19–21] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii None”
BackgroundBesselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60207-x · Cited by 1,367
Probiotics in the management of atopic eczema
Isolauri, E., Arvola, T., SÜtas, Y., Moilanen, E., & Salminen, S. (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00943.x · Cited by 974 · cited 1×
“Infants [15–18] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii, Bb12, L reuteri One mechanical choking episode reported”
BackgroundProbiotics: A novel approach in the management of food allergy
Majamaa, H., & Isolauri, E. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70093-9 · Cited by 918 · cited 1×
“Infants [15–18] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii, Bb12, L reuteri One mechanical choking episode reported”
BackgroundProbiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg, J. Z., Ma, S. S., Saxton, J. D., Martzen, M. R., Vandvik, P. O., Thorlund, K., Guyatt, G. H., & Johnston, B. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub3 · Cited by 741
Lactobacillus Sepsis Associated With Probiotic Therapy
Land, M. H., Rouster-Stevens, K., Woods, C. R., Cannon, M. L., Cnota, J., & Shetty, A. K. (2005) · Pediatrics · doi:10.1542/peds.2004-2137 · Cited by 599 · cited 1×
“Nine cases of overt sepsis have been reported [57–63], asso-”
BackgroundKhalesi, S., Sun, J., Buys, N., & Jayasinghe, R. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03469 · Cited by 516
Rayes, N., Seehofer, D., Theruvath, T., Schiller, R. A., Langrehr, J. M., Jonas, S., Bengmark, S., & Neuhaus, P. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00649.x · Cited by 478 · cited 2×
“Immunocompromised [12–14] Pediacoccus pentosaceus, Leuconostoc mesenteroides, Lactobacillus paracasei subspecies paracasei F19, Lactobacillus plantarum, LGG, L.”
BackgroundRayes, N., Seehofer, D., Hansen, S., Boucsein, K., M??ller, A. R., Serke, S., Bengmark, S., & Neuhaus, P. (2002) · Transplantation · doi:10.1097/00007890-200207150-00021 · Cited by 476 · cited 2×
“Immunocompromised [12–14] Pediacoccus pentosaceus, Leuconostoc mesenteroides, Lactobacillus paracasei subspecies paracasei F19, Lactobacillus plantarum, LGG, L.”
Background
Research works printed but not linked: 3
- Kukkonen, 2008, Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial, Pediatrics, 122, 8, 10.1542/peds.2007-1192 · DOI · Paper page
- Trautmann, 2008, Fungemia due to Saccharomyces cerevisiae var. boulardii, Chemother J, 17, 57
- Lestin, 2003, Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities, Dtsch Med Wochenschr, 128, 2531
Cited by
Items 801–900 of 1,000
PHARMACY STUDENTS' KNOWLEDGE, ATTITUDES AND PRACTICES ABOUT PROBIOTICS
Albayrak, A., & Mülazım, Ş. (2024) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.33483/jfpau.1458564 · Cited by 1
Other Precipitating Factors for AECHB
Wang, B., Guo, J., Li, L., Chen, T., Guo, C., & He, Y.-W. (2019) · Springer eBooks · doi:10.1007/978-94-024-1606-0_6 · Cited by 1
Бончужна, М. В., Мажак, К. Д., Мотика, О. І., Слесарчук, О. М., & Топорович, О. І. (2024) · Актуальні проблеми профілактичної медицини · doi:10.32782/2786-9067-2023-25-2 · Cited by 1
Post-Covid-19 irritable bowel syndrome – importance of diet therapy and probiotic therapy
Grońska, D., & Drzewowska, K. (2022) · Medycyna Ogólna i Nauki o Zdrowiu · doi:10.26444/monz/155260 · Cited by 1
Probióticos podem ser usados como adjuvante ao tratamento periodontal?
Lourenço, T. G. B., & Medeiros, F. (2022) · E-Acadêmica · doi:10.52076/eacad-v3i2.136 · Cited by 1
Role of Synbiotics in Inflammatory Lung Diseases
Ashique, S., Kumar, S., Upadhyay, A., Garg, A., Mishra, N., Kumar, P., Dua, K., Farid, A., & Hussain, A. (2024) · Springer eBooks · doi:10.1007/978-981-99-5575-6_3 · Cited by 1
Mutukumira, A. N., & Todorov, S. D. (2024) · Foods · doi:10.3390/foods13121817 · Cited by 1
“However, experimental studies clearly show that microbial cultures from different origins can be applied to fermentation processes or as probiotics, when they are suitable from a technological point of view, than to the provision of health benefits [6].”
Ćosić, A., Islam, N., & Hromić‐Jahjefendić, A. (2023) · Periodicals of Engineering and Natural Sciences (PEN) · doi:10.21533/pen.v11i2.3438 · Cited by 1
“In such cases, the introduction of probiotics to the human gut microbiome may result in sepsis, bacteraemia and even death [8], [9].”
BackgroundRecent Advances in Biosensors for the Determination of Probiotics
Yendurı, S., Hegde, B., & Koppuravuri, N. P. (2025) · Journal of Analytical Chemistry · doi:10.1134/s1061934824604973 · Cited by 1
Determination of D-Lactic Acid Production
Pandey, S., Chaudhari, A., & Dwivedi, M. (2022) · Methods and protocols in food science · doi:10.1007/978-1-0716-2509-5_9 · Cited by 1
Role of Probiotics in Medical Practice
Mollah, M. A. H., & Pervez, M. (2018) · Journal of Bangladesh College of Physicians and Surgeons · doi:10.3329/jbcps.v36i2.36064 · Cited by 1
Guo, Y., Zou, S., Yang, X., Li, R., Fu, W., Xu, C., Zhang, F., & Yang, X. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1680593 · Cited by 1
“The use of inactivated probiotics or their metabolites naturally avoids risks associated with live bacteria, such as mutations during growth and replication, as well as antibiotic resistance gene transfer (Doron and Snydman, 2015; Wang et al., 2020).”
Li, J., Liu, Y., & Jia, L. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11074-y · Cited by 1
ZHULDUZBAYEVA, A. Z., MUKAZHANOV, A. N., Tekebayeva, Z. B., Теmirbekova, A., Бегманович, А. А., Kulzhanova, K., Аманбаев, А. А., Shoaib, N., Nurbekova, Z., & Temirkhanov, A. Z. (2026) · МИКРОБИОЛОГИЯ ЖӘНЕ ВИРУСОЛОГИЯ · doi:10.53729/mv-as.2026.01.02 · Cited by 1
Nutritional intervention of probiotic as functional food
Kumari, N., & Bassi, P. (2024) · AIP conference proceedings · doi:10.1063/5.0227841 · Cited by 1
Chaiyasut, C., Sivamaruthi, B. S., Sirilun, S., Tirawat, Y., & Sittiprapaporn, P. (2019) · International Conference on Electrical Engineering/Electronics, Computer, Telecommunications and Information Technology (ECTI-CON) · doi:10.1109/ecti-con47248.2019.8955200 · Cited by 1
Considering Role of Probiotic on Respiratory Disease: Is Probiotic Possible to Treat COVID-19?
Kurniawati, E. M., Rahmawati, N. A., & SurgeanVeterini, A. (2021) · Indian Journal of Forensic Medicine & Toxicology · doi:10.37506/ijfmt.v15i2.14998 · Cited by 1
Utilizing the Gut Microbiome as a Therapeutic Target for Liver Disease – Narrative Review
Ayer, D., Trovato, A., & Tadros, M. S. (2023) · Journal of Translational Gastroenterology · doi:10.14218/jtg.2023.00027 · Cited by 1
Csikó, G., Palócz, O., Várhidi, Z., Sátorhelyi, P., Erdélyi, B., & Jurkovich, V. (2026) · Veterinary Research Communications · doi:10.1007/s11259-026-11264-7 · Cited by 1
“Although generally regarded as safe, probiotics may theoretically induce a range of side effects, including systemic infections (Doron and Snydman 2015), harmful metabolic activities, excessive immune activation in susceptible individuals, disruption of the host’s resident microbiota and horizontal…”
Probiotics: Popping the Prevalence and Parental Perspective
Parry, G., & Tuthill, D. P. (2021) · American Journal of Pediatrics · doi:10.11648/j.ajp.20210701.17 · Cited by 1
“[13, 23] Probiotics are classified as a food product and so are not subjected to the same ‘manufacturing and quality control’ standards as medications.”
BackgroundKim, D., Cho, M.-J., Lee, Y., Kil, E., Byun, S.-J., & Lee, S. (2021) · Research Square · doi:10.21203/rs.3.rs-170758/v1 · Cited by 1
“Cases are very rare, but probiotic infections such as bacteremia and endocarditis mediated by Lactobacilli and Bi dobacterium in immunocompromised patients have been reported (Doron and Snydman 2015; Gouriet et al. 2012).”
BackgroundMicroorganismos como medicamentos, ¿Podemos gestionar la microbiota?
Blanco, P. M. (2020) · UCrea (University of Cantabria) · Cited by 1
Manual da Associação Portuguesa de Farmacêuticos Hospitalares sobre Antimicrobianos
Fernandez-Llimos, F. (2022) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Неонатологія, хірургія та перинатальна медицина, 2021, Том ХІ, № 3
(2021) · DSpace BSMU · doi:10.24061/2413-4260.xi.3.41.2021 · Cited by 1
Probiotic characterization and spore production optimization of Lysinibacillus sp. MK212927
El-Sayed, S. E., & Messiha, A. A. (2026) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-026-13755-8 · Cited by 1
Pharmacologic Considerations in Oncology Critical Care
Patel, T., McGovern, E. M., Wolfe, D., Lewis, M. E., & Chowdhury, M. (2016) · InTech eBooks · doi:10.5772/64599 · Cited by 1
“6There have been several case reports of infections caused by organisms consistent with probiotic strains including but7not limited to Saccharomyces boulardii, Lactobacilli, Lactobacillus acidophilus, and Lactobacillus casei [39].”
Background"Suplementos ergogénicos e probióticos: O Papel Do Farmacêutico Comunitário"
Venda, M. J. F. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
A Holistic Approach to Improve Metabolic Health: A Practical Review
Harris, P., & Varón, J. (2025) · Journal of Independent Medicine · doi:10.71189/jim/2025/v01n04a03 · Cited by 1
Cheng, J. (2016) · Helda - University of Helsinki Institutional Repository · Cited by 1
Ogwiji, M., Jatau, I. D., Hyelavala, F. J., & Apollos, E.-E. (2024) · Journal of Animal Science and Veterinary Medicine · doi:10.31248/jasvm2024.478 · Cited by 1
Destro, T. M. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Esposito, A., & Bossi, P. (2023) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2023.2264182 · Cited by 1
“However, other studies [24] showed no efficacy in limiting ciD, and a caution in the use of probiotics in immunocompromised patients should be adopted due to the risk of infections [25,26].”
BackgroundThe Gut Microbiome of Premature Infants: An Ecological Analysis of a Probiotic Intervention Study
Samara, J. (2021) · doi:10.11575/prism/39342 · Cited by 1
Karaçam, S. (2021) · Bilecik Şeyh Edebali University Institutional Repository · Cited by 1
batu, Z. (2018) · Hacettepe University Institutional Repository (hacettepe.edu.tr) · Cited by 1
Dong, J., Zhou, Y., Huang, L., Wang, C., Wei, J., Abuduxukuer, K., Shi, W., Li, Y., Luo, J., & Peng, Q. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1527029 · Cited by 1
Abdelaty, M., Al-Solami, L., Al-Harbi, M., & El-Regal, M. A. A. (2021) · Journal of Applied Aquaculture · doi:10.1080/10454438.2021.1973937 · Cited by 1
“Probiotics are commonly considered healthy for use, but they can cause associations between pathogens and unexpected health hazards in unusual cases (Doron and Snydman 2015).”
BackgroundJung, H.-K., Kim, J.-H., Park, J., Kim, Y., Sohn, M., & Park, C. (2024) · Korean Journal of Veterinary Service · doi:10.7853/kjvs.2024.47.1.19 · Cited by 1
Ajayi, A. O., & Ajenifuja, O. A. (2025) · Nigerian Journal of Basic and Applied Sciences · doi:10.4314/njbas.v32i1.5 · Cited by 1
“The LAB are a diverse group of microorganisms that play a vital role in food fermentation and some of them have been recognized for their potential probiotic potential (Doron and Snydman, 2015).”
Uso de probióticos en la regulación de la microbiota intestinal humana y su impacto en la salud
Abuchaibe, W., & Mercedes, C. (2018) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Madhumathi, I., Ramesh, V., Rathakrishnan, B., Abirami, B., Gunasekaran, K., Kumar, T. S., Jeyasankar, P., Raja, G., Selvam, K., Rajendran, S., et al. (2026) · Gut microbes reports · doi:10.1080/29933935.2026.2668863
“33 Probiotic strains may carry transferable antibiotic resistance genes, 22,33 and underreporting of adverse effects in trials hinders risk evaluation.”
Cardiovascular and Pulmonary Wellness
IsHak, W. W., & Herrera, N. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.008
Wellness in Endocrine and Metabolic Disorders
Clevenger, S., Eskander, L., Lin, T. Y., & IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.013
The Concept of Wellness in Psychiatric and Substance-Use Disorders
Awad, A. G. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.006
Mays, A. M., Whiteman, E., & Rosen, S. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.015
Wellness Interventions for Chronicity and Disability
Klimowicz, A., Schussel, L., & IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.044
Positive Neuropsychology, Cognitive Rehabilitation, and Neuroenhancement
Pimental, P. A., O'Hara, J. B., Christopher, J., & Ciampanelli, A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.030
Mindfulness, Meditation, and Yoga
Budd, K. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.028
Pharmaceuticals and Alternatives for Wellness
Parisi, T., Heath, B., Wen, R. Y., & IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.024
Screening and Assessment Methods for Wellness
Greenberg, J. M., Castillo, E. G., IsHak, W. W., & Wells, K. B. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.002
Gastrointestinal System and Wellness
Robbins, L., & Feldman, E. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.009
Targeting the Gut Microbiome in Cancer Treatment
Čierniková, S., Ševčíková, A., Kasperova, B., Drgoňa, Ľ., & Mego, M. (2025) · Springer eBooks · doi:10.1007/978-3-032-00771-1_263
Targeting the Gut Microbiome in Cancer Treatment
Čierniková, S., Ševčíková, A., Kasperova, B., Drgoňa, Ľ., & Mego, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_263-1
Developing Purpose, Meaning, and Achievements
Vilhauer, J. S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.041
Sleep, Rest, and Relaxation in Improving Wellness
Ngor, A., & IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.026
Herrera, N., & IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.040
Circadian Rhythm in the Digital Age
Ezzat-Velinov, M., & Guarneri, M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.035
Marin, K., Tobia, G., Bakhoum, A., Naghdechi, L., Korouri, S., & IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.027 · Cited by 1
Acupuncture, Herbs, and Ayurvedic Medicine
Postolov, L., & Gilberg-Lenz, S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.031
The Personalized Wellness Life Plan
IsHak, W. W., Bart, R., Gohar, Y., Lorea, N., Eskander, L., Chang, T., Cohen, S., Furman, K., Nayyar, P. P., & DeBonis, K. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.050
IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.053
Wellness in Cancer and Neoplastic Diseases
Bashmi, L., & IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.018
Chaudhry, M., Gordon, A., Tadros, E., Sun, C., Tobia, G., & IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.019
Wellness Interventions for Physicians and Healthcare Professionals
Goldenberg, M., & Danovitch, I. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.021
The Arts in Health Settings: Inspirational, Educational, and Therapeutic Approaches to Wellness
Bucciarelli, A., Ellison, G. K., Sommer, E. K., & Spooner, H. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.036
IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.051
Lundy, J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.022
Wellness and the Genito-Urinary System
EILBER, K. S., & Lee, U. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.010
Exercise, Dance, Tai Chi, Pilates, and Alexander Technique
Altug, Z. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.025
Connection, Compassion, and Community
Hedrick, R., & Jones, K. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.043
Work, Love, Play, and Joie de Vivre
Groningen, N. V., IsHak, W. W., Ganjian, S., Ong, M. K., & Slusser, W. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.045
Neurological and Neurosurgical Disorders and Wellness
Ding, K., & Yang, I. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.007
Wellness and Whole-Person Care
Hutchinson, T. A., & Hutchinson, N. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.049
Sgarbossa, C., Meyyappan, A. C., Forth, E., Bromley, H., & Milev, R. V. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1663719
“Literature has re fl ected that short-term adverse events such as bloating, fl atulence, diarrhea, irritable bowels, constipation, abdominal pain, fever, and nausea can result from microbial therapeutics, which may impact an individual ’ s adherence to treatment (42 – 44).”
Louy, C., Sweet, C., Pollock, G. A., de Zagon, C., Louy, Z., Weiss, J. M., & Maher, D. P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.017
Wellness in Children and Adolescents
Zanko, C., & Stuber, M. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.016
Kilbaş, E. P. K., & Altındiş, M. (2023) · Flora the Journal of Infectious Diseases and Clinical Microbiology · doi:10.5578/flora.20239902
The Role of Gut Microbiota in Acute Myeloid Leukemia
Inglezou, L., Konstantinidis, T. G., Skeva, A., Malkots, B., Panagiotopoulos, E., Sakka, V., Spanoudakis, E., Panopoulou, M. I., Kotsianidis, Ι., & Liapis, K. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15103571
“Infections caused by probiotics have been reported in individuals, including cases of fungemia due to Saccharomyces species [62].”
Probiotics in the Prevention and Management of Antibiotic-Resistant Infections
Marzi, M., & Tunç, A. K. (2026) · Fenerbahçe Üniversitesi Sağlık Bilimleri Dergisi · doi:10.56061/fbujohs.1817657
Probiotics and Infection Prevention
Chan, C. W., Perry, W. A., & Doron, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-98427-4_22
Self-citationCrews, J. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00259-4
Current Paradigms and Diversity of Probiotic Microbes
Singh, B., Mal, G., Kalra, R. S., & Marotta, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-65455-8_3
Probiotics for managing non-alcoholic fatty liver disease: efficacy and mechanistic insights
Ghosh, S., Ghosh, A. J., Adhikari, M. D., Tiwary, B. K., & Saha, T. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-01861-3
“Tolerability refers to how well individuals can handle probiotic supplementation without experiencing adverse effects [ 232, 233 ].”
USO DE PROBIÓTICOS NA PRÁTICA CLÍNICA DO TRANSTORNO DO ESPECTRO AUTISTA
Portela, B. S., Souza, T. S., & Lima, D. M. (2022) · RECIMA21 - Revista Científica Multidisciplinar · doi:10.47820/recima21.v3i6.1553
Coca, M. R., Pérez-Fernández, C., Ruiz‐Sobremazas, D., Morales‐Navas, M., Colomina, M. T., López-Granero, C., & Sánchez-Santed, F. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.04.621894
Integrative approaches to head and neck cancer
McCurdy, M. R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30194-0.00020-5
A Mechanism of Antimicrobial Resistance and a Mitigation Strategy
Bulow, C. (2018) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/5vzy-r748
Abbas, P., Mayangsari, C. P., & Ovaditya, S. Z. (2023) · Jurnal Pengabdian Masyarakat Dalam Kesehatan · doi:10.20473/jpmk.v5i2.43807
Chapter 20: Prebiotics and Probiotics
Wilhelm, S. M., & Kale-Pradhan, P. B. (2020) · The American Pharmacists Association eBooks · doi:10.21019/9781582123172.ch20
Effects of probiotics on psychological issues in people with fibromyalgia: a systematic review
Nakhostin-Ansari, A., Khosravipour, N., Jafari, S. P., Ahmadi, S., Rabiei, Z., Khorasani, N. M., & Janzadeh, A. (2026) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000004726
“Some serious adverse events related to probiotic use, such as systemic infection, GI ischemia, and alterations in metabolic activity, have been reported in vulnerable populations, including individuals with critical illnesses and those who are immunocompromised [ 35–37 ] .”
Hygiene, J. O. P. M. A. (2023) · PubMed Central · doi:10.15167/2421-4248/jpmh2023.64.2s1
“Numerosi studi hanno verificato l’assenza di rischio per quanto riguarda l’uso di probiotici appartenenti al gene-re Bacillus nell’uomo [28-30].”
Backgroundde Matos, F. E. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.74.2018.tde-23022018-110245
Prenatal and neonatal probiotic intake in pediatric allergy
Shahali, Y., Mojgani, N., & Dadar, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823733-5.00029-5
Probióticos: Seguros e Eficazes?
Gomes, A. R. D., Gonçalves, C. A. F., Santos, N. M. D. S., Costa, C. D. S., & Calou, I. B. F. (2025) · Cuadernos de Educación y Desarrollo · doi:10.55905/cuadv17n11-013
Soliman, M. A., Basem, Y., Mohamed, H., Mansour, S., & Abdelmonem, R. (2025) · International Journal of Clinical Medical Research · doi:10.61466/ijcmr4010002
Food and mood: healthy eating for mental health with chronic kidney disease
Jackson, H. S. (2023) · Journal of Kidney Care · doi:10.12968/jokc.2023.8.sup6.s22
Microbiota and infection prevention: making space for probiotics in healthcare
Naghibi, M., & Day, R. O. (2018) · Gastrointestinal Nursing · doi:10.12968/gasn.2018.16.8.28
Kanjee, Z., Allegretti, J. R., Alonso, C. D., & Burns, R. B. (2023) · Annals of Internal Medicine · doi:10.7326/m23-0754
Probiotic Use for the Prevention of Antibiotic-Associated Clostridium difficile Infection.
Menninga, N. J., Chung, I., & Barnett, S. G. (2019) · PubMed Central
Metadata
- Authors
- Doron, S., & Snydman, D. R.
- Affiliations
- Tufts Medical Center (US)
- Corresponding author
- Doron, Shira
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-28
- Volume
- 60
- Issue
- suppl_2
- Pages
- S129-S134
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC4490230
- OpenAlex
- W2027617880
- Cited by
- 942
- References
- 91
- Citations by year
- 2026: 89 · 2025: 105 · 2024: 112 · 2023: 105 · 2022: 99 · 2021: 100 · 2020: 135 · 2019: 85 · 2018: 55 · 2017: 32 · 2016: 18 · 2015: 7
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k23at003391-03)
- National Center for Complementary and Integrative Health (K23 AT-003391, 5K23 AT003391-03)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, probiotic safety, adverse events, systemic infection, immunostimulation, gene transfer, gastrointestinal adverse effects, risk assessment
- MeSH terms
- Clinical Trials as Topic, Humans, Lactobacillus, Risk, Saccharomyces, United States, Fungemia, Sepsis, Probiotics, Gene Transfer, Horizontal, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.